Justice secretary David Lammy is facing a backlash from members of his own party over the scrapping of jury trials, with one ...

The Young and the Restless spoilers for the episode airing on December 2, 2025, reveal a tense day in both Genoa City and Los Angeles. Noah’s situation becomes more dangerous, while Sharon and Nick ...

Abbott Laboratories ABT1.77%increase; green up pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS 0.14%increase; green up pointing triangle in a deal valued at about ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Nick Offerman stars in a new Carnival Cruise Line ad campaign called “Find Your Fun Again.” The actor discussed enjoying the cruise ship's water park, ropes course, and hibachi dinner while filming.

North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...

The biggest question surrounding Lane Kiffin is his future at Ole Miss. Perhaps the second biggest question is, if Kiffin were to announce his departure from the Rebels, would the Ole Miss ...

Abbott Laboratories could be looking to acquire Exact Sciences, according to a report from Bloomberg, citing people close to the deal. News of the rumored deal caused Madison, WI-based Exact Sciences ...

Shares of Exact Sciences (EXAS) continued to rise in the premarket on Thursday, adding ~18% after the cancer test maker agreed to be acquired by Abbott Laboratories (ABT) in an all-cash deal worth ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...